Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21
The peptide's exceptional selectivity for senescent cells, combined with its well-characterized mechanism of FOXO4-p53 interaction disruption, provides researchers with powerful capabilities for investigating senescence biology that were previously impossible to study
SURMOUNT-4: the maintenance question This trial demonstrated that continuing tirzepatide after achieving weight loss maintained the results, while stopping led to substantial regain
Conclusion We demonstrated the OCCT as a tool to identify gut microbial signatures and guide personalized carnitine consumption
10.1097/01.hjh.0000242399.60838.14 151 KimY
Therapeutic peptides: current applications and future directions
